Next Article in Journal
Process Development for Fabricating 3D-Printed Polycaprolactone-Infiltrated Hydroxyapatite Bone Graft Granules: Effects of Infiltrated Solution Concentration and Agitating Liquid
Next Article in Special Issue
A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years
Previous Article in Journal
The Relationship between Lipoprotein A and the Prevalence of Multivessel Coronary Artery Disease in Young Patients with Acute Myocardial Infarction: An Observational Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Patients with Taste Disorders in a Hospital’s Dental Department and Strategies for Taste Disorders

Department of Oral Diagnosis and Medicine, Faculty of Dental Medicine, Graduate School of Dental Medicine, Hokkaido University, Kita-13 Nishi-7, Kita-ku, Sapporo 060-8586, Japan
*
Author to whom correspondence should be addressed.
Biomedicines 2024, 12(9), 2160; https://doi.org/10.3390/biomedicines12092160
Submission received: 21 August 2024 / Revised: 19 September 2024 / Accepted: 23 September 2024 / Published: 23 September 2024

Abstract

:
Background/Objectives: A retrospective study was conducted to clarify the clinical characteristics of taste disorder cases at the Department of Oral Medicine of Hokkaido University Hospital. The subjects were 322 taste disorder patients (86 male, 236 female, average age: 66 (13.1) years, mean duration of disorder: 15.2 (20.0) months) who were treated at our department from 2007 to 2018. Methods: Associations between symptoms and classification were examined. Results: When looking at the taste symptoms, 154 cases of quantitative taste disorder were observed as taste loss, abscission, and dissociative taste disorder, and 168 cases of qualitative taste disorder were observed as spontaneous abnormal taste, dysgeusia, and maltaste. There was no relationship between sex and quantitative/qualitative taste disorders at V = 0.08. When looking at the causes of taste disorders, the majority were psychogenic, idiopathic, and oral diseases. Conclusions: Approximately 20% of taste disorders are caused by oral diseases, so it should be noted that oral diseases such as oral candidiasis and xerostomia can cause taste disorders and that many of them can be improved with oral treatment.

1. Introduction

Taste is sensed by gustatory cells in taste buds located in the mucous membranes [1,2]. Taste receptor cells are mainly classified into type I, type II, and type III cell types, depending on their structure and gene expression [1,2]. There are two types of taste receptors, namely G protein-coupled taste receptors and ion channel taste receptors, which are sweet and bitter or salty and sour receptors, respectively [1,2]. Taste substances dissolve in saliva and, subsequently, are converted into gustatory signals that travel to the primary taste cortex [1,2]. The taste signal is transmitted to the hypothalamus and amygdaloid nucleus, which control emotions [1,2]. Furthermore, olfactory and gustatory information are integrated in the cerebral cortex, where they are recognized as food [1,2]. Therefore, taste disorders are thought to be associated with abnormalities in taste receptor mechanisms ranging from the periphery to the central nervous system. The number of patients visiting medical institutions with complaints of taste abnormalities is increasing year-by-year because of the stresses of modern society, an increase in the number of underlying diseases and commonly used drugs (polypharmacy), and the rapid progression towards a super-aging society [3]. Currently, zinc deficiency is considered to be one of the main causes of taste disorders in Japan, and reports from the otorhinolaryngology field indicate that the overall effectiveness of zinc treatments is approximately 70% [3,4,5,6,7]. However, the proportion of causes of taste disorders differs from that reported by otorhinolaryngology, and our department has experienced many cases in which zinc supplementation therapy was not effective [8,9]. Since the treatments of diseases differ depending on the clinical department that treats them, it is necessary to clarify the characteristics of the patients being treated. Many of the existing case reports of taste disorders are related to COVID-19, cancer, and drugs [10,11,12]. Oral diseases that cause abnormalities in taste include oral candidiasis, xerostomia, and stomatitis. Oral candidiasis is an opportunistic infection characterized by the abnormal growth of Candida and is characteristically common in elderly people [13]. Candida colonizes the mucous membranes on the tongue’s surface and inhibits the diffusion of tastants [14]. In addition, Candida invasion of mucous membranes causes damage to the peripheral nervous system. It is believed that taste abnormalities develop through these mechanisms. There are also other causes; for example, some patients with severe periodontitis complain of a bitter taste from the inflammatory exudate. Another example is xerostomia, which is broadly classified into peripheral and central and is often caused by insufficient water intake or salivary gland disease. However, it may also be caused by central diabetes insipidus. Additionally, stomatitis is frequently caused by malnutrition, inflammatory diseases, such as Crohn’s disease, and gastrointestinal diseases. While not in itself a taste disorder, the pain of stomatitis may make it difficult to recognize the true taste of food. Moreover, the malabsorption of nutrients due to gastrointestinal disease is another cause of taste disorders. Due to these myriad causes, patient interviews and examinations by multiple medical departments may be necessary. Although there are case reports of taste disorders in the field of otorhinolaryngology [7], there are almost no reports from dentistry. Most of the previous research elaborated on one or a few aspects of interest [4,10,11,12]. Therefore, the purpose of this study was to examine the characteristics of taste disorders in dentistry from a retrospective perspective, mainly regarding the subjective symptoms of taste disorders and the causes of taste disorders. Understanding the etiology will help us to develop treatment strategies.

2. Materials and Methods

2.1. Taste Test

The true purpose of taste tests is to evaluate whether taste buds function as receptors, whether the nerves transmit taste, and whether the brain can perceive taste.
For the assessment of gustatory sensitivity, the filter paper disc (FPD) method, which is covered by health insurance, was used in our hospital. FPD, which uses a 5 mm diameter piece of filter paper soaked in a taste solution, can evaluate the cognitive threshold of four taste regions of the chorda tympani, glossopharyngeal, and greater petrosal nerves, respectively [6]. We stimulated the test area for 3 s using taste solutions at different ascending concentrations and measured the cognitive threshold [15,16]. For a long time, Taste Disc® was commonly used as a FPD tool, but it has been discontinued and is no longer available on the market as of February 2022. The test was therefore conducted using reagents made at our own facility. FPD uses 5 levels for 4 taste stimuli (Table 1). A high score on FPD indicates a lowered perceptual sensitivity. Elderly people generally have an increased taste perception threshold; therefore, the reference range changes depending on age.
In the whole mouth method, four types of taste solutions were dropped onto the dorsum of the tongue at the following concentrations (Table 2), and the cognitive thresholds were tested by tasting the samples for 2 to 3 s. Taste perception threshold testing followed the criteria in the table below; when No. 5 could not be recognized, taste loss was diagnosed. The reference ranges for these qualitative tests vary depending on the facility, and the normal values for cognitive thresholds vary greatly from person to person, so they alone are not sufficient for evaluating taste disorders. Therefore, a comprehensive diagnosis must be made.

2.2. Patients

This retrospective study included 322 patients with a history of taste complaints (mean duration: 15.2 (20.0) months) who were diagnosed with taste disorders at Hokkaido University Hospital between 2007 and 2018. In Japan, oral medicine has been established as a subspecialty of oral surgery. At our facility, the patients were diagnosed based on the criteria listed in Figure 1. All of them were diagnosed by an oral surgeon specialist with over 10 years of experience who was accredited by the Japanese Society of Oral and Maxillofacial Surgeons (S.K.-i.). There were 86 male patients and 236 female patients, with an average age of 66.3 (13.1) years. Since most patients who visit our facility are female, there was no imbalance in taste abnormalities based on sex.

2.3. Zung Self-Rating Depression Scale (SDS)

The Zung self-rating depression scale (SDS) is an instrument that screens for depression. The SDS is available in many languages. The reliability and validity of the SDS has been demonstrated in Japanese.

2.4. Ethical Aspects

The study data and informed consent were obtained in accordance with the Declaration of Helsinki, and the study protocol was approved by the Ethics Review Board of Hokkaido University Hospital (Approval No. 018-0381; approved in June 2019).

2.5. Statistical Analysis

The relationship between sex and taste disorder classification was examined using Cramer’s coefficient of association (V). A relationship was defined when V was ≥ 0.3. A relative evaluation was performed by calculating percentages from the observed frequencies for each category. The data were analyzed using Excel (Microsoft® Excel® for Microsoft 365MSO (version 2306, build 16.0.16529.20164, 64 bit)) and R version 4.3.1 (16 June 2023) (copyright © 2023, The R Foundation for Statistical Computing).

3. Results

As shown in Table 3, there were no imbalances in age and serum zinc levels between the two groups (Supplementary Materials). Moreover, there was no relationship between sex and taste disorder classification (V = 0.082, 95% confidence interval: 0.005–0.19) (Supplementary Materials). The differences between quantitative and qualitative taste abnormalities, classified by their causes, are shown in Figure 2. Qualitative taste abnormalities were 1.5 times more likely to be psychogenic and zinc deficiency-related than quantitative taste abnormalities. Prior to the coronavirus outbreak, most cases were caused by psychogenic causes, oral diseases, and idiopathic diseases. The most common oral disease was glossitis, caused by oral candidiasis.

4. Discussion

These results showed that there was no relationship between taste abnormalities, age, sex, and serum zinc levels (Supplementary Materials). To our knowledge, there were no reports showing a relationship between sex and the cause of taste abnormalities. Regarding serum zinc levels, no relationship was observed, consistent with the trend in the two-category data from Nin et al. [7,15]. It is possible that zinc is only associated with certain taste abnormalities. Compared to the results compiled by Nin et al., common cold- and systemic disease-related taste disorders were twice as rare in our results, and drug-induced cases were five times less common [7,15]. On the other hand, cases due to oral diseases were 3.6 times more common [7,15]. These differences may be due to patients and referring physicians using appropriate judgment to select appropriate departments for hospitalization and treatment.
A comprehensive diagnosis should be made by utilizing taste recognition threshold tests, blood tests, and visual inspections. In our study, taste disorders were classified by symptoms and by cause.
Taste disturbances can be classified into four main categories: hypogeusia (a decreased sensitivity to taste modalities), dysgeusia (taste confusion), phantogeusia (phantom taste), and ageusia (loss of taste) [15,16]. The total loss of taste is rare. Hypogeusia, dysgeusia, and ageusia can be detected using the FPD method. Quantitative taste abnormalities constitute either a difficulty in detecting or an inability to detect some or all tastes. These can also be quantitatively evaluated using the FPD method. Qualitative taste abnormalities are taste disorders that have other symptoms. Since qualitative taste abnormalities are difficult to objectively assess, they are often assessed by asking patients about their subjective symptoms. As an alternative, cause-related classification allows for the selection of different cause-based therapies as treatments (Figure 1). There are also many causes that depend on the location of the disorder for classification; taste disorders generally occur at conductive, receptor, and neurological sites. However, this classification is incomplete because sometimes the cause is unknown.
In Japan, although oral zinc therapy was considered to be low-level evidence in a previous clinical review, polaprezinc has been used to treat taste disorders since 2011, with approval granted for its off-label use [4,7,8,15,16]. Polaprezinc is zinc acetate dihydrate, which is also available in Europe. Other treatment options are not covered by health insurance. Our previous study showed that ethyl loflazepate monotherapy could also be a treatment option for patients with idiopathic and psychogenic taste disorders [9].
In this study, psychogenic taste disorders accounted for 30–40% of cases, zinc deficiency-related taste disorders accounted for approximately 10%, and oral diseases accounted for 20% of cases. Based on the case series and descriptive statistics in this study, approximately 40–50% of the patients could be treated using polaprezinc or ethyl loflazepate. If oral disease can be ruled out as a cause based on the breakdown of causes of taste abnormalities experienced by patients visiting a dental clinic, the best course of action would be to explore the cause while taking zinc supplements. However, according to the cause-based classification, more than half of the cases required treatments other than zinc supplementation. The Zung self-rating depression scale (SDS) could be useful as a diagnostic aid to help with cause-based classification. It is useful for screening for psychogenic or depressive disorders; therefore, it can be calculated that using SDS as a diagnostic aid for psychogenic taste disorders would be effective for approximately one in four people (113/322 × 0.75 = 0.263).
In Japan, it is believed that zinc supplementary therapy is an effective treatment for taste disorders [3,4,12,15,16]. Based on the results of the study and the fact that no relationship was found between the type of taste disorder and serum zinc level, serum zinc levels constitute only reference-level information. Ingredients other than zinc in polaprezinc may be involved in the treatment of taste disorders [8]. Ito et al. considered carnosine to be one of the active ingredients with a treatment effect [8]. Considering previous studies as well as our study, it is possible that zinc and polaprezinc do not affect all taste disorders. These results may be due to changes over time rather than the drug. Since there are no drugs that are guaranteed to be effective against taste disorders, it is desirable to identify the causative disease and treat it. Therefore, based on the clinical results herein, further development of this basic research is desired.
A research limitation was the research design, which comprised a cross-sectional study. Without a cohort study, the effects of any interventions cannot be investigated.
The criteria for determining treatment results were ambiguous. Some patients complained of taste abnormalities even if their taste perception thresholds were normal. However, we sometimes need to deal with the discrepancy between a patient’s symptoms and objective results. Therefore, a better evaluation is desirable. For example, a Likert scale is a symmetrical evaluation system with five, seven, or nine points, comprising answers such as improved, slightly improved, unchanged, slightly worsened, and worsened. Likert scales would therefore be useful as a unified evaluation criterion for taste abnormalities and disorders.

5. Conclusions

It is important to identify the causes of taste disorders, as their treatment varies depending on the cause. Patients with taste disorders who visit dentists have a high proportion of psychogenic and oral diseases. Approximately half of these patients may require zinc supplementation therapy. Further research should establish standardized treatment evaluation criteria. In addition to testing the taste perception threshold, a Likert scale would be a suitable evaluation criterion. We also should provide appropriate treatments.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/biomedicines12092160/s1. Excel file: our calculation processes.

Author Contributions

Conceptualization, K.-i.S. and Y.K.; methodology, T.I. and H.K.; software, K.-i.S.; validation, T.I.; formal analysis, T.I.; investigation, K.-i.S.; resources, K.-i.S. and S.H.; data curation, T.O.; writing—original draft preparation, T.I.; writing—review and editing, T.I. and K.-i.S.; visualization, T.I.; supervision, Y.K.; project administration, Y.K.; funding acquisition, K.-i.S. All authors have read and agreed to the published version of the manuscript.

Funding

The APC was funded by Lotte Co., Ltd., Tokyo, Japan.

Institutional Review Board Statement

This retrospective study was conducted with the approval of the Hokkaido University Hospital Independent Clinical Research Review Committee (Approval No. 018-0381; approved in June 2019). All the study procedures were performed in accordance with the principles of the Declaration of Helsinki.

Informed Consent Statement

This article does not disclose identifiable information about any of the participants in any form. Hence, consent for publication is not applicable in this case.

Data Availability Statement

The data presented in this study are openly available in this paper.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Mainland, J.D.; Barlow, L.A.; Munger, S.D.; Millar, S.E.; Vergara, M.N.; Jiang, P.; Schwob, J.E.; Goldstein, B.J.; Boye, S.E.; Martens, J.R.; et al. Identifying Treatments for Taste and Smell Disorders: Gaps and Opportunities. Chem. Senses 2020, 45, 493–502. [Google Scholar] [CrossRef]
  2. Savard, D.J.; Ursua, F.G.; Gaddey, H.L. Smell and Taste Disorders in Primary Care. Am. Fam. Physician 2023, 108, 240–248. [Google Scholar] [PubMed]
  3. Sakata, K.-I.; Hashimoto, A.; Kambe, T.; Sato, J.; Ohga, N.; Yamazaki, Y.; Koyachi, M.; Tatsuki, I.; Okada, M.; Taro, O.; et al. Expression analysis of zinc-metabolizing enzymes in the saliva as a new method of evaluating zinc content in the body: Two case reports and a review of the literature. J. Med. Case Rep. 2024, 18, 198. [Google Scholar] [CrossRef] [PubMed]
  4. Sakagami, M.; Ikeda, M.; Tomita, H.; Ikui, A.; Aiba, T.; Takeda, N.; Inokuchi, A.; Kurono, Y.; Nakashima, M.; Shibasaki, Y.; et al. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: Randomized, double-blind, placebo-controlled, multi-center study. Acta Oto-Laryngol. 2009, 129, 1115–1120. [Google Scholar] [CrossRef] [PubMed]
  5. Braud, A.; Boucher, Y. Taste disorder’s management: A systematic review. Clin. Oral Investig. 2020, 24, 1889–1908. [Google Scholar] [CrossRef] [PubMed]
  6. Hsieh, J.W.; Daskalou, D.; Macario, S.; Voruz, F.; Landis, B.N. How to Manage Taste Disorders. Curr. Otorhinolaryngol. Rep. 2022, 10, 385–392. [Google Scholar] [CrossRef] [PubMed]
  7. Nin, T.; Tanaka, M.; Nishida, K.; Yamamoto, J.; Miwa, T. A clinical survey on patients with taste disorders in Japan: A comparative study. Auris Nasus Larynx 2022, 49, 797–804. [Google Scholar] [CrossRef] [PubMed]
  8. Ito, K.; Yuki, S.; Nakatsumi, H.; Kawamoto, Y.; Harada, K.; Nakano, S.; Saito, R.; Ando, T.; Sawada, K.; Yagisawa, M.; et al. Multicenter, prospective, observational study of chemotherapy-induced dysgeusia in gastrointestinal cancer. Support. Care Cancer 2022, 30, 5351–5359. [Google Scholar] [CrossRef] [PubMed]
  9. Sakata, K.-i.; Hato, H.; Sato, J.; Iori, T.; Ohga, N.; Watanabe, H.; Yamazaki, Y.; Kitagawa, Y. Ethyl loflazepate as a treatment for patients with idiopathic and psychogenic taste disorder. BioPsychoSocial Med. 2022, 16, 16. [Google Scholar] [CrossRef] [PubMed]
  10. Wang, J.; Liu, R.; Ma, H.; Zhang, W. The Pathogenesis of COVID-19-Related Taste Disorder and Treatments. J. Dent. Res. 2023, 102, 1191–1198. [Google Scholar] [CrossRef] [PubMed]
  11. Rademacher, W.M.H.; Aziz, Y.; Hielema, A.; Cheung, K.-C.; de Lange, J.; Vissink, A.; Rozema, F.R. Oral adverse effects of drugs: Taste disorders. Oral Dis. 2020, 26, 213–223. [Google Scholar] [CrossRef] [PubMed]
  12. Okuni, I.; Otsubo, Y.; Ebihara, S. Molecular and Neural Mechanism of Dysphagia Due to Cancer. Int. J. Mol. Sci. 2021, 22, 7033. [Google Scholar] [CrossRef] [PubMed]
  13. Itagaki, T.; Sakata, K.-i.; Hasebe, A.; Kitagawa, Y. Exploratory Study of the Relationship between an Oral Fungal Swab Test and Patient Blood Test Data. Microorganisms 2023, 11, 2887. [Google Scholar] [CrossRef] [PubMed]
  14. Leung, R.; Covasa, M. Do Gut Microbes Taste? Nutrients 2021, 13, 2581. [Google Scholar] [CrossRef] [PubMed]
  15. Nin, T.; Tsuzuki, K. Diagnosis and treatment of taste disorders in Japan. Auris Nasus Larynx 2024, 51, 1–10. [Google Scholar] [CrossRef] [PubMed]
  16. Nomura, Y.; Toi, T.; Ikeda, M.; Ikeda, A.; Tanaka, M.; Oshima, T. Prognostic factors of recovery with medication in patients with taste disorders. PLoS ONE 2020, 15, e0237270. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Diagnosis and treatment of taste disorders. At our facility, diagnosis and treatment are performed according to this flow diagram.
Figure 1. Diagnosis and treatment of taste disorders. At our facility, diagnosis and treatment are performed according to this flow diagram.
Biomedicines 12 02160 g001
Figure 2. Aggregated results by taste disorder cause classification. The number of cases of quantitative and qualitative taste abnormalities and the combined ratio of both are shown in (a), (b), and (c), respectively.
Figure 2. Aggregated results by taste disorder cause classification. The number of cases of quantitative and qualitative taste abnormalities and the combined ratio of both are shown in (a), (b), and (c), respectively.
Biomedicines 12 02160 g002
Table 1. Filter paper disk (FPD) test.
Table 1. Filter paper disk (FPD) test.
Taste Disc®No. 1No. 2No. 3No. 4No. 5Molecular Weight
Sucrose: S0.3%2.5%10%20%80%342.2965
Sodium Chloride (NaCl): N0.3%1.25%5%10%20%58.44
Tartaric Acid: T0.02%0.2%2%4%8%150.0868
Quinine Hydrochloride Dihydrate: Q0.001%0.02%0.1%0.5%4%396.9083
Sucrose: S; sodium chloride (NaCl): N; tartaric acid: T; quinine hydrochloride dihydrate: Q.
Table 2. Whole mouth method.
Table 2. Whole mouth method.
No. 1No. 1.5No. 2No. 2.5No. 3No. 4No. 5
S2.9 μmol5.8 μmol8.8 μmol17.5 μmol29.2 μmol58.4 μmol2337 μmol (80%)
N3.4 μmol5.1 μmol6.8 μmol10.3 μmol17.1 μmol85.6 μmol3422.3 μmol (20%)
T0.3 μmol0.7 μmol2.0 μmol6.7 μmol10 μmol20 μmol533 μmol (8%)
Q2.5 pmol13.0 pmol50.0 pmol130 pmol250 pmol1.3 μmol101 μmol (4%)
Sucrose: S; sodium chloride (NaCl): N; tartaric acid: T; quinine hydrochloride dihydrate: Q.
Table 3. Patient demographic data.
Table 3. Patient demographic data.
Taste Disorder ClassificationQuantitative Taste AbnormalitiesQualitative Taste AbnormalitiesStandardized Difference
Male47390.16
Female107129
Age (mean (SD)) year67.3 (14.7)65.5 (11.4)0.13
Age (median (range)) year67 (24–90)72 (18–94)Not applicable
Zn (mean (SD)) μg/dL73.1 (16.3) 73.4 (15.8)0.02
Standard deviation: SD.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Itagaki, T.; Sakata, K.-i.; Okura, T.; Kobayashi, H.; Hayata, S.; Kitagawa, Y. Patients with Taste Disorders in a Hospital’s Dental Department and Strategies for Taste Disorders. Biomedicines 2024, 12, 2160. https://doi.org/10.3390/biomedicines12092160

AMA Style

Itagaki T, Sakata K-i, Okura T, Kobayashi H, Hayata S, Kitagawa Y. Patients with Taste Disorders in a Hospital’s Dental Department and Strategies for Taste Disorders. Biomedicines. 2024; 12(9):2160. https://doi.org/10.3390/biomedicines12092160

Chicago/Turabian Style

Itagaki, Tatsuki, Ken-ichiro Sakata, Taro Okura, Hirokazu Kobayashi, Sadasuke Hayata, and Yoshimasa Kitagawa. 2024. "Patients with Taste Disorders in a Hospital’s Dental Department and Strategies for Taste Disorders" Biomedicines 12, no. 9: 2160. https://doi.org/10.3390/biomedicines12092160

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop